417 related articles for article (PubMed ID: 27975209)
21. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
Toft-Nielsen M; Madsbad S; Holst JJ
Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
[TBL] [Abstract][Full Text] [Related]
22. Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.
Aitken ML; Szkudlinska MA; Boyko EJ; Ng D; Utzschneider KM; Kahn SE
Diabetologia; 2020 May; 63(5):1055-1065. PubMed ID: 31993716
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
24. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide.
Øhrstrøm CC; Worm D; Højager A; Andersen D; Holst JJ; Kielgast UL; Hansen DL
Diabetes Obes Metab; 2019 Sep; 21(9):2142-2151. PubMed ID: 31144430
[TBL] [Abstract][Full Text] [Related]
25. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
Goldfine AB; Mun EC; Devine E; Bernier R; Baz-Hecht M; Jones DB; Schneider BE; Holst JJ; Patti ME
J Clin Endocrinol Metab; 2007 Dec; 92(12):4678-85. PubMed ID: 17895322
[TBL] [Abstract][Full Text] [Related]
26. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
[TBL] [Abstract][Full Text] [Related]
27. Unraveling, contributing factors to the severity of postprandial hypoglycemia after gastric bypass surgery.
Herzig D; Schiavon M; Tripyla A; Lehmann V; Meier J; Jainandunsing S; Kuenzli C; Stauffer TP; Dalla Man C; Bally L
Surg Obes Relat Dis; 2023 May; 19(5):467-472. PubMed ID: 36509672
[TBL] [Abstract][Full Text] [Related]
28. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction.
Rabiee A; Magruder JT; Salas-Carrillo R; Carlson O; Egan JM; Askin FB; Elahi D; Andersen DK
J Surg Res; 2011 May; 167(2):199-205. PubMed ID: 21414635
[TBL] [Abstract][Full Text] [Related]
29. GIP(3-30)NH
Gasbjerg LS; Christensen MB; Hartmann B; Lanng AR; Sparre-Ulrich AH; Gabe MBN; Dela F; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
Diabetologia; 2018 Feb; 61(2):413-423. PubMed ID: 28948296
[TBL] [Abstract][Full Text] [Related]
30. Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.
Øhrstrøm CC; Worm D; Kielgast UL; Holst JJ; Hansen DL
Obes Surg; 2020 Mar; 30(3):1038-1045. PubMed ID: 31907828
[TBL] [Abstract][Full Text] [Related]
31. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery.
McLaughlin T; Peck M; Holst J; Deacon C
J Clin Endocrinol Metab; 2010 Apr; 95(4):1851-5. PubMed ID: 20133462
[TBL] [Abstract][Full Text] [Related]
32. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
33. Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery.
Magro DO; Cazzo E; Kotze PG; Vasques ACJ; Martinez CAR; Chaim EA; Geloneze B; Pareja JC; Coy CSR
Obes Surg; 2018 Feb; 28(2):378-388. PubMed ID: 28776152
[TBL] [Abstract][Full Text] [Related]
34. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
35. The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery.
Hindsø M; Hedbäck N; Svane MS; Møller A; Martinussen C; Jørgensen NB; Dirksen C; Gasbjerg LS; Kristiansen VB; Hartmann B; Rosenkilde MM; Holst JJ; Madsbad S; Bojsen-Møller KN
Diabetes; 2023 Mar; 72(3):336-347. PubMed ID: 36478039
[TBL] [Abstract][Full Text] [Related]
36. Study protocol for a randomised, double-blind, placebo-controlled crossover trial assessing the impact of the SGLT2 inhibitor empagliflozin on postprandial hypoglycaemia after gastric bypass.
Ferreira A; Emara AFA; Herzig D; Melmer A; Vogt AP; Nakas CT; Facchinetti A; Dalla Man C; Bally L
BMJ Open; 2022 Sep; 12(9):e060668. PubMed ID: 36123073
[TBL] [Abstract][Full Text] [Related]
37. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies.
Hindsø M; Svane MS; Hedbäck N; Holst JJ; Madsbad S; Bojsen-Møller KN
Surg Obes Relat Dis; 2021 Jul; 17(7):1383-1391. PubMed ID: 33771461
[TBL] [Abstract][Full Text] [Related]
38. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ
Surg Obes Relat Dis; 2007; 3(6):597-601. PubMed ID: 17936091
[TBL] [Abstract][Full Text] [Related]
39. Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol.
Lobato CB; Winding CT; Bojsen-Møller KN; Martinussen C; Veedfald S; Holst JJ; Madsbad S; Jørgensen NB; Dirksen C
Diabet Med; 2024 Jun; 41(6):e15320. PubMed ID: 38551152
[TBL] [Abstract][Full Text] [Related]
40. Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes.
Dalsgaard NB; Gasbjerg LS; Helsted MM; Hansen LS; Hansen NL; Skov-Jeppesen K; Hartmann B; Holst JJ; Vilsbøll T; Knop FK
Bone; 2023 May; 170():116687. PubMed ID: 36754130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
